Brain Cancer Trial, Recruiting NCT05831631 Sponsor: Pietro Mortini, MD, Prof. Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT05831631
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be an adult aged 18 or older
  • You must be able to understand and agree to take part in the trial yourself
  • You must have a brain tumor, either one that started in the brain or one that has spread to the brain from elsewhere in the body
  • You must need brain surgery or a specialist radiation or biopsy procedure to treat your tumor

Who may not be able to join:

  • Anyone who does not meet all of the above requirements would not be eligible to join this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Pietro Mortini, MD, Prof., IRCCS San Raffaele Scientific Institute

Phone: 0226435568

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pietro Mortini, MD, Prof.
Registry
ClinicalTrials.gov
Start date
1 August 2022
Est. completion
31 July 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Baseline leucocytes count; Baseline leucocytes immunophenotype; Baseline tumor-infiltrating lymphocytes count; Baseline tumor-infiltrating leucocytes immunophenotype

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov